Kevin Krause

President, Chief Executive Officer, Board Director @ ArrePath | AI/ML Enabled Antibacterial Drug Discovery

Role
CEO and President at Arrepath
Location
San Francisco, CA, US
LinkedIn followers
500 followers
General Business & ManagementView LinkedIn profile

About Kevin Krause

Biotechnology executive with 25+ years of experience in Operations, R&D, Commercial Launch, Product Launch/Strategy/Lifecycle Management, and Business Development, specializing in Infectious Diseases and Pulmonology.• Proven expertise in company formation (e.g, AN2 Therapeutics, Inc.) and in leading operational restructuring and termination (e.g, Cerexa, Inc. and Achaogen, Inc.).• Extensive experience in engaging with investor relations teams, sell-side analysts, media, and investors (VC, PE, and public funds) for investor presentations, updates, and competitive landscape discussions, including pre-IPO, PIPE, and IPO transactions.• Accomplished Business Development leader; managed the full lifecycle from deal sourcing to execution for in-licensing opportunities (pre-clinical to commercial assets) and portfolio divestitures; led deal teams, financial modeling, commercial and scientific assessments, and competitive intelligence.• Led cross-functional teams to develop program strategies, make label expansion investment decisions, conduct market research, develop sales forecasts and launch plans, and determine pricing strategies.• Provided strategic oversight and authored five FDA New Drug Applications and five EMA Marketing Authorization Applications; participated in five U.S. FDA Advisory Committees.• Extensive project leadership and accountability within global cross-disciplinary teams throughout all R&D phases, from early discovery to Phase 3/launch, across multiple brands including Vibativ™, Teflaro™, Colobreathe™, AVYCAZ™, Zemdri™, and Quinsair™.

Experience

  1. CEO and President

    Arrepath

    Nov 2024 — Present

Education

  • University of California, Berkeley, Haas School of Business

    MBA, Finance and Corporate Strategy

    2009 — 2012

  • San Francisco State University

    Bachelor of Science, Cell and Molecular Biology, Minor in Chemistry

    1994 — 1998

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Kevin Krause — CEO and President at Arrepath in San Francisco, CA, US | Unifers